chartexchange

Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference

GlobeNewswire Inc. | Nov 12, 2026 7:05 AM EST

MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer, will present at the virtual Bell Potter Healthcare Conference on Thursday, November 19, 2026 at 12:00 p.m. AEDT.

Read original article